Tak, P P <br/><br/>
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial.  [electronic resource] 

 -  Annals of the rheumatic diseases  Jan 2011 
 - 39-46 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/ard.2010.137703  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--drug therapy<br/>Disease Progression<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Drug Therapy, Combination--methods<br/>Humans<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Rituximab<br/>Severity of Illness Index<br/>Treatment Outcome<br/>Young Adult